This inventor holds 1 USPTO granted patent. Top assignee: Blueprint Medicines Corporation. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Baptiste Tournade: Innovator in Synthetic Methods for Treating Diseases
Introduction
Baptiste Tournade is an inventor based in Saint Leu d'Esserent, France. He is known for his work in developing synthetic methods and intermediates for producing compounds that treat diseases related to mutant KIT and PDGFRA. His innovative approach aims to address significant medical challenges through advanced chemical processes.
Latest Patent Applications
Baptiste Tournade has submitted a patent application titled "SYNTHETIC METHODS AND INTERMEDIATES FOR PRODUCING COMPOUNDS FOR TREATING KIT- AND PDGFRA-MEDIATED DISEASES." This application outlines methods and intermediates for creating Compound A or its pharmaceutical salts, which are essential for treating conditions associated with mutant KIT and PDGFRA.
Conclusion
Baptiste Tournade's contributions to synthetic methods in the pharmaceutical field highlight his commitment to addressing critical health issues. His ongoing work in this area may lead to significant advancements in treatment options for patients suffering from related diseases.